Association of sarcopenia with endocrine therapy toxicity in patients with early breast cancer.
Gabriel Francisco Pereira AleixoStephanie A ValenteWei WeiHalle C F MoorePublished in: Breast cancer research and treatment (2022)
The presence of sarcopenia in patients with EBC represents a potentially modifiable risk factor for more significant endocrine therapy side effects and reduced treatment tolerance.